Carregant...

ECF chemotherapy for liver metastases due to castration-resistant prostate cancer

INTRODUCTION: Most men with metastatic castration-resistant prostate cancer (CRPC) have biochemical response to docetaxel, but the objective response rate is low. Liver metastases are uncommon with CRPC and associated with shorter survival. More active treatment might benefit these patients. Epirubi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gupta, Shruti, Potvin, Kylea, Ernst, D. Scott, Whiston, Frances, Winquist, Eric
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216294/
https://ncbi.nlm.nih.gov/pubmed/25408803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!